๐๏ธ OncologyInjection (SC)
Elrexfio
Elranatamab
BCMA-directed bispecific T-cell engager for relapsed/refractory multiple myeloma.
Form
Injection (SC)
Uses
1
Side effects
5
Category
Oncology
01
What is Elrexfio used for?
- Relapsed/refractory multiple myeloma
02
Elranatamab side effects
Common side effects of Elranatamab include:
Cytokine release syndrome
Infections
ICANS (neurotoxicity)
Neutropenia
Anemia
CommonModerateLess common
03
Elranatamab warnings & precautions
- Black box: CRS and neurologic toxicity
- REMS required. Step-up dosing
- Serious infections
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Elrexfio in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.